The DOI matches its Crossref record; 19 of the 20 references it cites were found in a registry or an index.
Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy
Open accessAbstract
Adeno-associated viral (AAV) vectors have demonstrated considerable promise for gene therapy of inherited diseases. However, with a packaging size of <5 kb, applications have been limited to relatively small disease genes. Based on the finding that AAV genomes undergo intermolecular circular concatamerization after transduction in muscle, we have developed a paradigm to increase the size of delivered transgenes with this vector through trans-splicing between two independent vectors coadministered to the same tissue. When two vectors encoding either the 5′ or 3′ portions of the erythropoietin genomic locus were used, functional erythropoietin protein was expressed in muscle subsequent to the formation of intermolecular circular concatamers in a head-to-tail orientation through trans-splicing between these two independent vector genomes. These findings will allow for the application of AAV technologies to a wider variety of diseases for which therapeutic transgenes exceed the packaging limitation of present AAV vectors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“All of these methods require multiple vectors, and the efficiency of some of these methods is inherently limited by the efficiencies of intron processing or homologous recombination.”
From Effect of genome size on AAV vector packaging (2010) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recently, split vector systems, exploiting head-to-tail concatamerization formation, have been developed to circumvent the small packaging capacity of AAV genomes (13-16, 41, 52).”
From Packaging Capacity of Adeno-Associated Virus Serotypes: Impact of Larger Genomes on Infectivity and Postentry Steps (2005) · cites this paper as [52]
The cited source says what the claim attributes to it.
In the citing paper
“The trans-splicing method to expand the size of ORFs that can be successfully expressed using AAV vectors was originally developed in the laboratory of John Engelhardt 52,53 and has since been utilized in several studies with varying success (e.g., refs. 53-57 ).”
From Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids (2016) · cites this paper as [53]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Summerford, C., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1438-1445.1998 · Cited by 1,409
Use of Adeno-Associated Virus as a General Transduction Vector for Mammalian Cells
Muzyczka, N. (1992) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-75608-5_5 · Cited by 756
αVβ5 integrin: a co-receptor for adeno-associated virus type 2 infection
Summerford, C., Bartlett, J. S., & Samulski, R. J. (1999) · Nature Medicine · doi:10.1038/4768 · Cited by 711
Duan, D., Sharma, P., Yang, J., Yue, Y., Dudus, L., Zhang, Y., Fisher, K. J., & Engelhardt, J. F. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8568-8577.1998 · Cited by 522
Self-citationSamulski, R. J., Chang, L., & Shenk, T. E. (1987) · Journal of Virology · doi:10.1128/jvi.61.10.3096-3101.1987 · Cited by 449
Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
Qing, K., Mah, C., Hansen, J., Zhou, S., Dwarki, V., & Srivastava, A. (1999) · Nature Medicine · doi:10.1038/4758 · Cited by 443
Animal Model of Adenine-Induced Chronic Renal Failure in Rats
Yokozawa, T., Zheng, P., Oura, H., & Koizumi, F. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000183992 · Cited by 356
Biology of Adeno-associated Virus
Berns, K. I., & Giraud, C. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-80207-2_1 · Cited by 308
Clark, K. R., Liu, X., McGrath, J. P., & Johnson, P. R. (1999) · Human Gene Therapy · doi:10.1089/10430349950018427 · Cited by 306
Yang, J., Zhou, W., Zhang, Y., Zidon, T. M., Ritchie, T. L., & Engelhardt, J. F. (1999) · Journal of Virology · doi:10.1128/jvi.73.11.9468-9477.1999 · Cited by 201
Self-citation
Flagged first, then by citations
1 of the 20 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- N Muzyczka Curr Top Microbiol Immunol 158, 97–129 (1992).
- N Qu, J K Wen, E Li Chung Kuo Chung Hsi I Chieh Ho Tsa Chih 15, 222–224 (1995).
- F Zhang, P Laneuville, R F Gagnon, B Morin, A G Brox Exp Hematol 24, 1469–1474 (1996).
Cited by
Sorted by citations
Items 201–300 of 304
Li, Y., Wu, H.-L., & Liu, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179380 · Cited by 11
Delivering Large Therapeutic Genes for Muscle Gene Therapy
Lai, Y., Yue, Y., Bostick, B., & Duan, D. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1207-7_12 · Cited by 11
Self-citationMaurer, A. C., Benyamini, B., Whitney, O. N., Fan, V. B., Cattoglio, C., Kissiov, D. U., Dailey, G. M., Darzacq, X., Weitzman, M. D., & Tjian, R. (2025) · Nature Communications · doi:10.1038/s41467-025-56738-5 · Cited by 9
MAR-mediated integration of plasmid vectors for in vivo gene transfer and regulation
Puttini, S., van Zwieten, R. W., Saugy, D., Lekka, M., Högger, F., Ley, D., Kulik, A., & Mermod, N. (2013) · BMC Molecular Biology · doi:10.1186/1471-2199-14-26 · Cited by 10
Adeno-Associated Viral Gene Therapy for Retinal Disorders
Silva, S. R. D., McClements, M. E., Hankins, M. W., & MacLaren, R. E. (2015) · Neuromethods · doi:10.1007/978-1-4939-2306-9_9 · Cited by 10
Duchenne Cardiomyopathy Gene Therapy
Shin, J., Bostick, B., Fine, D. M., Yue, Y., & Duan, D. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1207-7_9 · Cited by 10
Self-citationChallenges for gene therapy for muscular dystrophy
Mendell, J. R., & Clark, K. R. (2006) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-996-0009-8 · Cited by 12
Locke, M., Ussher, J. E., Mistry, R. M., Taylor, J. A., & Dunbar, P. R. (2011) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2011.0153 · Cited by 12
Allikmets, R. L. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-186-4_5 · Cited by 9
Gene therapy for pituitary tumors: from preclinical models to clinical implementation
Castro, M. G., Goverdhana, S., Hu, J., Jovel, N., Yuan, X., & Lowenstein, P. R. (2003) · Frontiers in Neuroendocrinology · doi:10.1016/s0091-3022(02)00106-1 · Cited by 9
Gene Therapy of Atherosclerosis
Vähäkangas, E., & Ylä‐Herttuala, S. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-27661-0_30 · Cited by 8
Adenoassociated virus vectors for genetic immunization
Ponnazhagan, S. (2002) · Immunologic Research · doi:10.1385/ir:26:1-3:247 · Cited by 8
A KPI Framework for Process-based Benchmarking of Hospital Information Systems
Jahn, F., & Winter, A. (2011) · Studies in health technology and informatics · doi:10.3233/978-1-60750-806-9-542 · Cited by 8
Frisch, J., & Cucchiarini, M. (2016) · Stem Cells and Development · doi:10.1089/scd.2016.0106 · Cited by 7
Ning, K., Zhang, X. J., Feng, Z., Hao, S., Küz, Ç. A., Cheng, F., Park, S. Y., McFarlin, S., Engelhardt, J. F., Yan, Z., et al. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.101115 · Cited by 8
Self-citationThe Use of Specific AAV Serotypes to Stably Transduce Primary CNS Neuron Cultures
Malik, S. Z., Maronski, M., Dichter, M. A., & Watson, D. J. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-536-7_26 · Cited by 8
Adeno‐associated viral vectors for gene therapy
Flotte, T. R., & Berns, K. I. (2005) · Laboratory techniques in biochemistry and molecular biology · doi:10.1016/s0075-7535(05)31001-1 · Cited by 7
Palmieri, L., Ferrand, M., Hong, A. V., Richard, I., & Albini, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910444 · Cited by 7
Harnessing nucleic acid technologies for human health on earth and in space
Sarli, S. L., & Watts, J. K. (2022) · Life Sciences in Space Research · doi:10.1016/j.lssr.2022.08.006 · Cited by 6
Li, X., Yan, J., Xu, X.-Z., Wang, J., Cheng, L., Wang, T., Zuo, P., & Wang, D. W. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00676.x · Cited by 6
Progress in gene therapy for Duchenne muscular dystrophy
Clemens, P. R., & Duncan, F. J. (2001) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-001-0080-0 · Cited by 6
PCDH15 Dual-AAV Gene Therapy for Deafness and Blindness in Usher Syndrome Type 1FPreprint
Ivanchenko, M. V., Hathaway, D. M., Mulhall, E. M., Booth, K. T. A., Wang, M., Peters, C. W., Klein, A. J., Chen, X., Li, Y., György, B., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.09.566447 · Cited by 6
Clinical gene therapy restores hearing: a paradigm shift
Han, S., Chen, Z., Wang, D., Jiang, L., Fan, X., Zhong, J., Cui, C., Chen, Y., lv, J., Zhang, J., et al. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2025.07.007 · Cited by 5
Kabbani, M. A. A., Wunderlich, G., Köhler, C. N., & Zempel, H. (2021) · Biocell · doi:10.32604/biocell.2022.018144 · Cited by 5
Wu, H., Chaudhary, A., & Mahato, R. I. (2019) · Springer eBooks · doi:10.1007/978-3-030-00710-2_16 · Cited by 4
3rd Annual Dysferlin Conference 2–5 June 2009, Boston, Massachusetts, USA
Albrecht, D. E., Garg, N., Rufibach, L., Williams, B. A., Ioannidis, N. M., Hwang, E., & Mittal, P. (2009) · Neuromuscular Disorders · doi:10.1016/j.nmd.2009.08.005 · Cited by 4
Gene Therapy: Use of Viruses as Vectors
Nance, M. E., & Duan, D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95711-8 · Cited by 3
Self-citationGene Therapy for Retinal Diseases
Gopinath, C., Sarkar, S., & Ghosh, A. (2021) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-981-15-9184-6_30 · Cited by 3
Preclinical Study Design for rAAV
Flotte, T. R., Conlon, T. J., & Mueller, C. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-370-7_14 · Cited by 3
Gene Therapy Approaches to Ataxias
Lim, F., & Díaz‐Nido, J. (2009) · Current Gene Therapy · doi:10.2174/156652309787354649 · Cited by 3
A Method for Helper Virus-Free Production of Adeno-Associated Virus Vectors
Collaco, R. F., & Trempe, J. P. (2003) · Humana Press eBooks · doi:10.1385/1-59259-304-6:237 · Cited by 3
Gene therapy for inherited retinal diseases
Dhooge, P. P. A., Valkenburg, D., & Hoyng, C. B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816222-4.00017-4 · Cited by 3
Habib, N. A., Havlík, R., Jiao, L., Kiri, A., Jensen, S. L., Nicholls, J. P., Sarraf, C., Goldspink, G., Davies, A., Slavík, L., et al. (2004) · WestminsterResearch (University of Westminster) · Cited by 3
The persistence of alien genomes
Tattersall, P. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6239 · Cited by 3
Dong, W.-J., Wu, X., Liu, D., Li, J., Liu, G., Zu, Z.-X., Zhao, N., Hou, Y., & Liang, C. (2002) · Journal of Biomedical Science · doi:10.1007/bf02256072 · Cited by 3
Endothelium‐targeted Gene and Cell‐based Therapy for Cardiovascular Disease
Melo, L. G., Pachori, A. S., Kong, D., Gnecchi, M., & Dzau, V. J. (2007) · doi:10.1002/9780470988473.ch26 · Cited by 3
Adeno-Associated Virus and AAV Vectors for Gene Delivery
Carter, B. (2015) · CRC Press eBooks · doi:10.1201/b18002-6 · Cited by 3
Virus-based vectors for gene expression in mammalian cells: Adeno-associated virus
Xiao, X. (2003) · New comprehensive biochemistry · doi:10.1016/s0167-7306(03)38006-8 · Cited by 2
Bru, T., Galetto, R., Piver, É., Collin, C., Negroni, M., & Pagès, J. (2007) · Journal of Virological Methods · doi:10.1016/j.jviromet.2007.01.022 · Cited by 2
Gene Delivery and Gene Therapy for Alzheimer’s Disease
Woodbury, M. E., Kiyota, T., & Ikezu, T. (2015) · Neuromethods · doi:10.1007/978-1-4939-2306-9_4 · Cited by 2
Wu, H., & Mahato, R. I. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6486-0_24 · Cited by 3
Adeno-associated Virus and AAV Vectors for Gene Delivery
Carter, B., Burstein, H., & PELUSO, R. W. (2003) · CRC Press eBooks · doi:10.1201/9780824758608.ch5 · Cited by 2
Cardiac Cell and Gene Transfer
Metzger, J. M. (2002) · Humana Press eBooks · doi:10.1385/159259350x · Cited by 2
Virus Vectors for use in the Central Nervous System
Lehtonen, E., & Tenenbaum, L. (2003) · International review of neurobiology · doi:10.1016/s0074-7742(03)01002-x · Cited by 1
Use of recombinant angiostatin to prevent retinal neovascularization.
Berns, K. I., Meneses, P., Duvoisin, R. M., Laipis, P. J., & Hauswirth, W. W. (2001) · Europe PMC (PubMed Central) · Cited by 1
The Use of Viral Vectors to Enhance Cognition
Ikezu, T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-417042-1.00006-1 · Cited by 1
Application to Gene Therapy and Vaccination
Su, L., Bowers, W. J., Janelsins, M. C., & Federoff, H. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_52 · Cited by 1
Expressing Full-Length Dystrophin Using Adeno-Associated Virus
Kodippili, K., & Duan, D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809813-4.00013-2 · Cited by 1
Self-citationYan, Z., Lei-Butters, D. C. M., Zhang, Y., Žák, R., & Engelhardt, J. F. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.ft-274 · Cited by 1
Self-citationHuttner, N. A. (2003) · doi:10.5282/edoc.1420 · Cited by 1
Lai, Y., Yue, Y., Liu, M., & Duan, D. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.ft-246 · Cited by 1
Self-citationDevelopment of targeted gene delivery vectors to assess cardiac overexpresion of ACE2 in vivo
Shirley, R. (2008) · Enlighten: Theses (The University of Glasgow) · Cited by 1
Carter, B. (2003) · Drugs and the pharmaceutical sciences · doi:10.1201/9780203912331.ch8 · Cited by 1
Gene Delivery to Cardiovascular Tissue
Masson, R., Nicklin, S. A., & Baker, A. H. (2009) · Springer eBooks · doi:10.1007/978-1-84882-637-3_2 · Cited by 1
Gene Therapy: Back to the Basics
Hu, J. (2007) · Springer eBooks · doi:10.1007/978-0-387-40049-5_35
Novel Alternatives to Chemotherapy in Advanced Disease: Gene Transfer
Ghaneh, P., Halloran, C. M., Costello, E., & Neoptolemos, J. P. (2004) · Springer eBooks · doi:10.1007/978-1-85233-904-3_9
Molecular Neurosurgery in the Pituitary Gland
Castro, M. G., Jovel, N., Goverdhana, S., Hu, J., Yu, J. S., Ehtesham, M., Yuan, X., Greengold, D., Xiong, W., & Lowenstein, P. R. (2005) · KARGER eBooks · doi:10.1159/000084481
Karwacz, K. (2012) · UCL Discovery (University College London)
Integrating Viral Vectors for Gene Modifications
Mendel, G. L., Paszkiet, B., & Witek, R. P. (2011) · Wiley eBooks · doi:10.1002/9781118147177.ch9
Expanding AAV cargo capacity for gene therapy of Stargardt disease
Trapani, I. (2014)
Dressman, D. C. (2002) · D-Scholarship@Pitt (University of Pittsburgh)
Generation of enhanced gene delivery vectors by directed evolution of adeno-associated virus
Endell, J. (2006) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.5436
Maina, C. N. (2009) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1689
Mukai, H., Kawakami, S., & Hashida, M. (2008) · Drug Delivery System · doi:10.2745/dds.23.454
Interactions Between AAV-2 and HSV-1: Implications for Hybrid Vector Design
Glauser, D. L., & Fraefel, C. (2011) · Future Virology · doi:10.2217/fvl.11.13
Driskell, R. R., & Engelhardt, J. F. (2003)
Self-citationYu, D. L. (2015) · The Atrium (University of Guelph)
AAV2 vermittelte Transduktion von porcinem Myokard im Transplantationsmodell
Schulz, A. (2009) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.10823
Gene Transfer Strategies and Therapeutic Applications for Cardiovascular Ischemic Diseases
Engelhardt, J. F., Li, Q., & Ritchie, T. C. (2003) · Springer eBooks · doi:10.1007/978-2-8178-0761-4_24
Self-citationRecombinant AAV Vectors as Tools to Study and Treat Human Disorders
Cucchiarini, M. (2013) · Orthopedic & Muscular System · doi:10.4172/2161-0533.s1-e001
Engineering delivery and release of protein therapeutics for mammalian systems
Fluri, D. A. (2008) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-005708602
Parvovirus Vectors for the Gene Therapy of Cancer
Wong, K. K., & Chatterjee, S. (2002) · Elsevier eBooks · doi:10.1016/b978-012437551-2/50004-5
Adeno-Associated Virus-Based Vectors
Dutheil, N., & Bézard, E. (2013) · Neuromethods · doi:10.1007/978-1-62703-610-8_3
Novel Approaches for Pluripotent Reprogramming
Weltner, J. (2018) · Työväentutkimus Vuosikirja
Gene Therapy for Neoplastic Hematology in Transplant Setting
Castro, J. E., & Kipps, T. J. (2018) · Advances and controversies in hematopoietic transplantation and cell therapy · doi:10.1007/978-3-319-54368-0_13
Gene Therapy Approaches for Cochlear Repair
Richardson, R. T., & Gunewardene, N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.24135-7
Gene Therapy for Retinal Disease
McClements, M. E., & MacLaren, R. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800563-7.00011-7
Klefenz, H. (2002) · Wiley eBooks · doi:10.1002/3527600124.refs
Har-el, Y.-E., Fiegel, A. J., Dawson, M., Hanes, J. S., & Suh, J. (2003) · Drugs and the pharmaceutical sciences · doi:10.1201/9780203912898.ch16
Tattersall, P. J., & Cotmore, S. F. (2010) · Wiley eBooks · doi:10.1002/9780470688618.taw0227
Methods for In Vivo Gene Manipulation
Monteggia, L. M., & Xu, W. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190681425.003.0004
朱甫祥, 刘泽隆, 迟晓艳, 屈慧鸽, & 刘相钦 (2009) · Science in China Series C-Life Sciences (in Chinese) · doi:10.1360/zc2009-39-8-746
Induced Pluripotency: Current Reprogramming Methods and Areas for Improved Therapeutic CapabilitiesPreprint
Lu, B., & Horowitz, N. B. (2023) · doi:10.14293/pr2199.000455.v1
Advanced Therapy Medicinal Products: Clinical, Non-clinical, and Quality Considerations
Mastrobattista, E., Doevendans, E., van Til, N. P., Kemp, V., de Vrij, J., & Hoogendoorn, K. H. (2024) · Springer eBooks · doi:10.1007/978-3-031-30023-3_14
Efficiency of autofibroblasts in surgical treatment of parodontitis
Старостина, И. Г., Solovyeva, V. V., Юрьева, К. С., Shevchenko, K. G., Fedotov, V. P., Rizvanov, A. A., Deev, R. V., & Isaev, A. A. (2013) · Genes and Cells · doi:10.23868/gc120542
Current Perspectives on Gene and Cell-Based Therapies for Myocardial Protection, Rescue and Repair
Melo, L. G., Pachori, A. S., Kong, D., & Dzau, V. J. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-06214-2_15
Ciron, C. (2006) · OpenGrey (Institut de l'Information Scientifique et Technique)
La modularité de la dysferline peut-elle permettre le développement d'approches thérapeutiques?
Barthélémy, F. (2013) · theses.fr (ABES) · doi:10.70675/b51efb0fz3b2ez406dz8b41za40ff9115334
Chassagne, J. (2019) · theses.fr (ABES) · doi:10.70675/74df0299z4167z4397zb93fz28bc889326f4
Journou, M. (2021) · theses.fr (ABES) · doi:10.70675/9a618ac2za0a4z4e90zbdb3ze14482ffa655
Ballouhey, O. (2021) · theses.fr (ABES) · doi:10.70675/c92eabe1z7868z43c0z9df4zf6e02e91d61f
Controlled linking of AAV capsids enables coordinated multi-vector deliveryPreprint
Kim, Y., Ding, X., Yang, C., Lee, G., Gradinaru, V., & Park, J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.13.716639
Update on the Management of ABCA4 Retinopathy (Stargardt Disease)
Parameswarappa, D. C., Ratra, D., Chattannavar, G., & Padhy, S. K. (2026) · Ophthalmology and Therapy · doi:10.1007/s40123-026-01407-z
Calcium dysregulation in diabetic cardiomyopathy & heart failure with preserved ejection fraction
Ali, A., Sharma, V. M., & Aguilar-Sánchez, Y. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1872513
Gene Therapy: Medicine of the 21stCentury
Verma, I. M. (2003) · Research and perspectives in neurosciences · doi:10.1007/978-3-642-55543-5_10
Metadata
- Authors
- Yan, Z., Zhang, Y., Duan, D., & Engelhardt, J. F.
- Affiliations
- University of Iowa (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2000-06-06
- Volume
- 97
- Issue
- 12
- Pages
- 6716-6721
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC18714
- OpenAlex
- W2082328650
- Cited by
- 305
- References
- 20
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 9 · 2023: 10 · 2022: 5 · 2021: 12 · 2020: 12 · 2019: 14 · 2018: 9 · 2017: 10 · 2016: 7 · 2015: 11 · 2014: 9 · 2013: 14 · 2012: 7
- FWCI
- 13.07
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL058340, R01 HL58340)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK 54759, P30DK054759)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Keywords
- adeno-associated virus vectors, trans-splicing, erythropoietin, gene therapy
- MeSH terms
- Dependovirus, Anemia, Animals, Erythropoietin, Genetic Vectors, Kidney Failure, Chronic, Mice, Inbred C57BL, Muscles, Genetic Therapy, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
